Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Orthomyxoviridae Infections | 12 | 2014 | 69 | 1.930 |
Why?
|
| CD8-Positive T-Lymphocytes | 13 | 2012 | 648 | 1.920 |
Why?
|
| CD4-Positive T-Lymphocytes | 10 | 2021 | 620 | 0.910 |
Why?
|
| Influenza A virus | 7 | 2013 | 116 | 0.900 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 4 | 2009 | 86 | 0.860 |
Why?
|
| Interleukin-17 | 4 | 2010 | 88 | 0.780 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2013 | 244 | 0.620 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 2 | 2009 | 26 | 0.590 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2010 | 87 | 0.580 |
Why?
|
| Melanoma, Experimental | 2 | 2010 | 40 | 0.550 |
Why?
|
| Immunologic Memory | 7 | 2021 | 281 | 0.530 |
Why?
|
| Mice, Transgenic | 9 | 2012 | 1206 | 0.420 |
Why?
|
| Influenza, Human | 4 | 2013 | 191 | 0.390 |
Why?
|
| Interferon-gamma | 6 | 2012 | 551 | 0.380 |
Why?
|
| Mice | 18 | 2014 | 10289 | 0.370 |
Why?
|
| Mice, Knockout | 8 | 2012 | 1993 | 0.340 |
Why?
|
| Immunity, Cellular | 3 | 2013 | 171 | 0.310 |
Why?
|
| Animals | 22 | 2021 | 19648 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 9 | 2012 | 3230 | 0.300 |
Why?
|
| Influenza Vaccines | 2 | 2021 | 90 | 0.290 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2014 | 170 | 0.290 |
Why?
|
| Lymphotoxin-alpha | 2 | 2004 | 8 | 0.280 |
Why?
|
| Cells, Cultured | 6 | 2012 | 2093 | 0.280 |
Why?
|
| Adaptation, Biological | 1 | 2007 | 15 | 0.270 |
Why?
|
| Cross-Priming | 1 | 2007 | 16 | 0.270 |
Why?
|
| Cold Temperature | 1 | 2007 | 51 | 0.270 |
Why?
|
| Membrane Glycoproteins | 3 | 2004 | 661 | 0.260 |
Why?
|
| Mice, Inbred BALB C | 6 | 2012 | 868 | 0.250 |
Why?
|
| Antibody Formation | 1 | 2006 | 108 | 0.250 |
Why?
|
| Receptors, Antigen, T-Cell | 5 | 2010 | 281 | 0.230 |
Why?
|
| Ovalbumin | 3 | 2010 | 116 | 0.190 |
Why?
|
| Perforin | 4 | 2012 | 31 | 0.190 |
Why?
|
| Pore Forming Cytotoxic Proteins | 4 | 2012 | 34 | 0.190 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2004 | 207 | 0.190 |
Why?
|
| Cytotoxicity Tests, Immunologic | 2 | 2012 | 29 | 0.190 |
Why?
|
| Dendritic Cells | 1 | 2004 | 515 | 0.180 |
Why?
|
| Apoptosis | 1 | 2006 | 1032 | 0.180 |
Why?
|
| Lung Neoplasms | 2 | 2004 | 582 | 0.180 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2013 | 109 | 0.180 |
Why?
|
| Cell Line, Tumor | 3 | 2010 | 1370 | 0.150 |
Why?
|
| Lung | 4 | 2014 | 919 | 0.140 |
Why?
|
| Adoptive Transfer | 3 | 2012 | 147 | 0.140 |
Why?
|
| Chemokines | 3 | 2010 | 93 | 0.140 |
Why?
|
| Cell Proliferation | 2 | 2014 | 941 | 0.140 |
Why?
|
| T-Lymphocytes | 3 | 2007 | 986 | 0.140 |
Why?
|
| Disease Models, Animal | 5 | 2014 | 2050 | 0.130 |
Why?
|
| Neoplasms | 1 | 2006 | 1240 | 0.130 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 2010 | 147 | 0.130 |
Why?
|
| Cell Count | 2 | 2006 | 127 | 0.120 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2014 | 7 | 0.120 |
Why?
|
| Lymphoid Tissue | 1 | 2014 | 55 | 0.120 |
Why?
|
| Respiratory Mucosa | 1 | 2014 | 54 | 0.120 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 1554 | 0.120 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 1951 | 0.110 |
Why?
|
| Fas Ligand Protein | 2 | 2004 | 39 | 0.110 |
Why?
|
| Cell Movement | 2 | 2006 | 428 | 0.110 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2006 | 176 | 0.110 |
Why?
|
| Neoplasm Transplantation | 2 | 2004 | 161 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2010 | 588 | 0.110 |
Why?
|
| Survival Analysis | 2 | 2006 | 555 | 0.110 |
Why?
|
| Cell Division | 2 | 2004 | 443 | 0.100 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2012 | 22 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2013 | 84 | 0.100 |
Why?
|
| Viruses | 1 | 2013 | 78 | 0.100 |
Why?
|
| Virus Diseases | 1 | 2013 | 114 | 0.100 |
Why?
|
| Lymphocyte Activation | 2 | 2006 | 743 | 0.100 |
Why?
|
| Antigen Presentation | 2 | 2021 | 225 | 0.090 |
Why?
|
| Antigens, Viral | 3 | 2009 | 130 | 0.090 |
Why?
|
| Vaccinia | 1 | 2010 | 31 | 0.090 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2010 | 35 | 0.080 |
Why?
|
| Vaccinia virus | 1 | 2010 | 70 | 0.080 |
Why?
|
| Immunity | 1 | 2010 | 101 | 0.080 |
Why?
|
| Cytokines | 3 | 2013 | 912 | 0.080 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 452 | 0.080 |
Why?
|
| Epitopes | 2 | 2007 | 286 | 0.080 |
Why?
|
| Interleukin-10 | 1 | 2009 | 149 | 0.080 |
Why?
|
| Survival Rate | 2 | 2009 | 802 | 0.070 |
Why?
|
| B-Lymphocytes | 2 | 2012 | 550 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2012 | 1301 | 0.070 |
Why?
|
| Nucleoproteins | 1 | 2007 | 32 | 0.070 |
Why?
|
| Vaccines, Attenuated | 1 | 2007 | 33 | 0.070 |
Why?
|
| Nucleocapsid Proteins | 1 | 2007 | 35 | 0.070 |
Why?
|
| Viral Core Proteins | 1 | 2007 | 31 | 0.070 |
Why?
|
| Disease Outbreaks | 1 | 2007 | 102 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2006 | 70 | 0.060 |
Why?
|
| Pneumonia, Viral | 1 | 2009 | 205 | 0.060 |
Why?
|
| Immunoglobulin M | 1 | 2006 | 114 | 0.060 |
Why?
|
| Phylogeny | 1 | 2007 | 336 | 0.060 |
Why?
|
| Hemagglutinins, Viral | 1 | 2005 | 12 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2006 | 146 | 0.060 |
Why?
|
| Genes, MHC Class II | 1 | 2005 | 37 | 0.060 |
Why?
|
| Orthomyxoviridae | 1 | 2004 | 26 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2004 | 101 | 0.060 |
Why?
|
| Lymphoma, T-Cell | 1 | 2004 | 22 | 0.060 |
Why?
|
| Egg Proteins | 1 | 2004 | 23 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2010 | 774 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2004 | 297 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 446 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2004 | 133 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 385 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2004 | 214 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2004 | 184 | 0.050 |
Why?
|
| Weight Loss | 1 | 2006 | 263 | 0.050 |
Why?
|
| Neutrophils | 1 | 2006 | 363 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2004 | 365 | 0.050 |
Why?
|
| Transfection | 1 | 2004 | 675 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2004 | 400 | 0.050 |
Why?
|
| Pathogen-Associated Molecular Pattern Molecules | 1 | 2021 | 5 | 0.050 |
Why?
|
| Macrophages | 1 | 2006 | 1015 | 0.040 |
Why?
|
| Time Factors | 1 | 2007 | 3617 | 0.040 |
Why?
|
| Humans | 6 | 2021 | 59356 | 0.040 |
Why?
|
| Female | 2 | 2010 | 30704 | 0.030 |
Why?
|
| Bronchi | 1 | 2014 | 82 | 0.030 |
Why?
|
| Lymphocyte Cooperation | 1 | 2012 | 30 | 0.030 |
Why?
|
| Genes, Viral | 1 | 2012 | 55 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2012 | 99 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 258 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2012 | 223 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2012 | 512 | 0.020 |
Why?
|
| STAT4 Transcription Factor | 1 | 2010 | 7 | 0.020 |
Why?
|
| T-Box Domain Proteins | 1 | 2010 | 39 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2010 | 173 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2010 | 123 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 1300 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 446 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 125 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 644 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1550 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2013 | 1470 | 0.020 |
Why?
|
| Mutation | 1 | 2012 | 2455 | 0.010 |
Why?
|